August 7, 2024 Maria Dranishnikova Maker of transplant rejection drug Equillium sees shares rise after successful trial
August 6, 2024 Maria Dranishnikova Nonlethal weapons manufacturer Byrna announces $10 million stock buyback
August 6, 2024 Maria Dranishnikova Lymphoma drug developer Citius Pharma finalizing spin-off of oncology division
August 5, 2024 Maria Dranishnikova Infrastructure company IES Holdings announces $200 million buyback, stock jumps
August 2, 2024 Maria Dranishnikova Shares of AI-powered advertising technology provider Inuvo gain after loan announcement
August 2, 2024 Maria Dranishnikova Simply Wall St spotlights cloud platform provider Crexendo as undervalued
August 2, 2024 Maria Dranishnikova What KITS is doing to transform itself from an online glasses store into a major retailer
August 1, 2024 Maria Dranishnikova Vaping addiction treatment by Achieve Life Sciences gets breakthrough designation
August 1, 2024 Maria Dranishnikova Envoy stock jumps on news its hearing implants might become eligible for insurance coverage
July 31, 2024 Maria Dranishnikova Gap between Russell 2000 and Nasdaq Composite nears widest since 2001
July 31, 2024 Maria Dranishnikova Stock of brain cancer drug developer sinks 60% after deal announcement
July 30, 2024 Maria Dranishnikova Real estate broker La Rosa Holdings sees stock plummet after issuing new shares
July 29, 2024 Maria Dranishnikova Regenerative agriculture company Above Food’s update fails to impress investors
July 29, 2024 Maria Dranishnikova Alzheimer’s drug developer ProMIS loses over 20% of market capitalization in a day
July 26, 2024 Maria Dranishnikova Small-сap stocks could rise 15% in August – Fundstrat research head
July 23, 2024 Maria Dranishnikova Stock that drove small-cap fund outperformance of S&P 500 spotlighted
July 18, 2024 Albert Fahrutdinov Capital Economics and Natixis have doubts about sustainability of small-cap rally
July 12, 2024 Maria Dranishnikova Zacks advises investors to consider display manufacturer Daktronics